Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$18.11
Market cap
$198.08M
P/E Ratio
27.44
Dividend/share
N/A
EPS
$0.66
Enterprise value
$100.4M
Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a
Highlights
The company's quick ratio has surged by 64% YoY and by 8% QoQ
Medifast's debt has decreased by 21% YoY and by 8% from the previous quarter
The price to earnings (P/E) is 118% more than the last 4 quarters average of 12.7 and 99% more than the 5-year quarterly average of 13.9
MED's net income has shrunk by 94% YoY and by 75% QoQ
Key stats
What are the main financial stats of MED
Market
Valuations
Earnings
Shares outstanding
10.94M
Market cap
$198.08M
Enterprise value
$100.4M
Price to earnings (P/E)
27.44
Price to book (P/B)
0.96
Price to sales (P/S)
0.29
EV/EBIT
10.13
EV/EBITDA
3.69
EV/Sales
0.15
Revenue
$674.48M
EBIT
$9.92M
EBITDA
$27.22M
Free cash flow
$33.83M
Per share
Balance sheet
Liquidity
EPS
$0.66
Free cash flow per share
$3.09
Book value per share
$18.96
Revenue per share
$61.67
TBVPS
$26.63
Total assets
$291.24M
Total liabilities
$83.9M
Debt
$17.63M
Equity
$207.34M
Working capital
$152.6M
Debt to equity
0.09
Current ratio
3.11
Quick ratio
2.35
Net debt/EBITDA
-3.59
Margins
Efficiency
Dividend
EBITDA margin
4%
Gross margin
73.8%
Net margin
1.1%
Operating margin
1.6%
Return on assets
2.4%
Return on equity
3.6%
Return on invested capital
7.3%
Return on capital employed
4.5%
Return on sales
1.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MED stock price
How has the Medifast stock price performed over time
Intraday
-1.04%
1 week
-0.17%
1 month
4.74%
1 year
-72.77%
YTD
-73.06%
QTD
-5.38%
Financial performance
How have Medifast's revenue and profit performed over time
Revenue
$674.48M
Gross profit
$497.77M
Operating income
$10.85M
Net income
$7.33M
Gross margin
73.8%
Net margin
1.1%
MED's net income has shrunk by 94% YoY and by 75% QoQ
The operating income has shrunk by 93% YoY and by 68% QoQ
Medifast's net margin has plunged by 89% YoY and by 71% from the previous quarter
Medifast's operating margin has shrunk by 87% YoY and by 64% QoQ
Growth
What is Medifast's growth rate over time
Valuation
What is Medifast stock price valuation
P/E
27.44
P/B
0.96
P/S
0.29
EV/EBIT
10.13
EV/EBITDA
3.69
EV/Sales
0.15
The price to earnings (P/E) is 118% more than the last 4 quarters average of 12.7 and 99% more than the 5-year quarterly average of 13.9
The EPS has dropped by 94% year-on-year and by 75% since the previous quarter
MED's P/B is 89% below its 5-year quarterly average of 9.1 and 49% below its last 4 quarters average of 1.9
The equity has grown by 7% YoY
The P/S is 77% lower than the 5-year quarterly average of 1.3 and 25% lower than the last 4 quarters average of 0.4
MED's revenue is down by 45% year-on-year and by 12% since the previous quarter
Efficiency
How efficient is Medifast business performance
MED's ROE has shrunk by 95% YoY and by 75% QoQ
The return on invested capital has dropped by 95% year-on-year and by 72% since the previous quarter
The ROA has plunged by 94% YoY and by 75% from the previous quarter
The return on sales has dropped by 88% year-on-year and by 67% since the previous quarter
Dividends
What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Medifast financials performed over time
The company's quick ratio has surged by 64% YoY and by 8% QoQ
MED's current ratio has soared by 52% year-on-year and by 4.4% since the previous quarter
Medifast's debt is 91% less than its equity
Medifast's debt to equity has decreased by 25% YoY
Medifast's debt has decreased by 21% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.